These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35443850)

  • 1. α-synuclein as an emerging pathophysiological biomarker of Alzheimer's disease.
    Beatino MF; De Luca C; Campese N; Belli E; Piccarducci R; Giampietri L; Martini C; Perugi G; Siciliano G; Ceravolo R; Vergallo A; Hampel H; Baldacci F
    Expert Rev Mol Diagn; 2022 Apr; 22(4):411-425. PubMed ID: 35443850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive techniques and protein misfolding amplification assays for biomarker-guided reconceptualization of Alzheimer's and other neurodegenerative diseases.
    Campese N; Beatino MF; Del Gamba C; Belli E; Giampietri L; Del Prete E; Galgani A; Vergallo A; Siciliano G; Ceravolo R; Hampel H; Baldacci F
    Expert Rev Neurother; 2021 Sep; 21(9):949-967. PubMed ID: 34365867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
    Kurapova R; Chouliaras L; O'Brien JT
    Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between APOE Variants, Tau and α-Synuclein.
    Rodriguez-Vieitez E; Nielsen HM
    Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer's disease.
    Shim KH; Kang MJ; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2022 Dec; 14(1):201. PubMed ID: 36587215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
    Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
    Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays.
    Bellomo G; Paciotti S; Concha-Marambio L; Rizzo D; Wojdaƚa AL; Chiasserini D; Gatticchi L; Cerofolini L; Giuntini S; De Luca CMG; Ma Y; Farris CM; Pieraccini G; Bologna S; Filidei M; Ravera E; Lelli M; Moda F; Fragai M; Parnetti L; Luchinat C
    Mol Neurodegener; 2023 Apr; 18(1):20. PubMed ID: 37005644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
    Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
    Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
    Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
    Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases.
    Campese N; Palermo G; Del Gamba C; Beatino MF; Galgani A; Belli E; Del Prete E; Della Vecchia A; Vergallo A; Siciliano G; Ceravolo R; Hampel H; Baldacci F
    Expert Rev Proteomics; 2021 Jan; 18(1):27-48. PubMed ID: 33545008
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies.
    Sensi SL; Russo M; Tiraboschi P
    Handb Clin Neurol; 2023; 192():187-218. PubMed ID: 36796942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer's Disease.
    Monge-García V; García-Ayllón MS; Sáez-Valero J; Sánchez-Payá J; Navarrete-Rueda F; Manzanares-Robles J; Gasparini-Berenguer R; Romero-Lorenzo R; Cortés-Gómez MA; Monge-Argilés JA
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577877
    [No Abstract]   [Full Text] [Related]  

  • 16. Seed amplification and RT-QuIC assays to investigate protein seed structures and strains.
    Standke HG; Kraus A
    Cell Tissue Res; 2023 Apr; 392(1):323-335. PubMed ID: 35258712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study.
    Yoshinaga S; Yamanaka T; Miyazaki H; Okuzumi A; Hiyama A; Murayama S; Nukina N
    Biochem Biophys Res Commun; 2020 Feb; 522(3):655-661. PubMed ID: 31785806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
    García-Ayllón MS; Monge-Argilés JA; Monge-García V; Navarrete F; Cortés-Gómez MA; Sánchez-Payá J; Manzanares J; Gasparini-Berenguer R; Leiva-Santana C; Sáez-Valero J
    J Neurochem; 2019 Jul; 150(2):218-230. PubMed ID: 31077373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
    Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.